Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months

Hypertension

Volumn 57, Issue 5, 2011, Pages 911-917

  Krum, Henry ^a  

^a NONE

Author keywords

blood pressure; hypertension; renal sympathetic denervation

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IBUPROFEN;

ADULT; AGED; ARTERY DISSECTION; ARTERY RUPTURE; ARTICLE; AUSTRALIA; BLOOD PRESSURE REGULATION; CATHETER BASED RENAL SYMPATHETIC DENERVATION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DENERVATION; DIABETES MELLITUS; FALSE ANEURYSM; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INGUINAL REGION; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; RADIOFREQUENCY;

AGED; ANALYSIS OF VARIANCE; BLOOD PRESSURE; CATHETERS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; SYMPATHECTOMY; TREATMENT OUTCOME;

EID: 79955477242     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.163014     Document Type: Article

References (13)

1. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43:10-17. (Pubitemid 38031904)
2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance ofusual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913. (Pubitemid 35472129)
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Eval-uation, and Treatment of High Blood Pressure. Hypertension. 2003;42: 1206-1252. (Pubitemid 37553153)
4. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mus-solino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics: 2010 update-a report from the American Heart Association. Circulation. 2010;121:e46-e215.
5. World Health Organization (WHO). Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva, Swit-zerland: World Health Organization; 2009.
6. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365:217-223. (Pubitemid 40138015)
7. Sarafidis PA, Bakris GL. Resistant hypertension: an overview of eval-uation and treatment. JAm Coll Cardiol. 2008;52:1749-1757.
8. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009; 373:1275-1281.
9. Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903-1909.
10. Hansen JM, Abildgaard U, Fogh-Andersen N, Kanstrup IL, Bratholm P, Plum I, Strandgaard S. The transplanted human kidney does not achieve functional reinnervation. Clin Sci (Lond). 1994;87:13-20. (Pubitemid 24220266)
11. Kaye DM, Esler M, Kingwell B, McPherson G, Esmore D, Jennings G Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans. Circulation. 1993; 88:1110-1118. (Pubitemid 23264028)
12. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009;361:932-934.
13. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J. Preserving renal function in adults with hypertension and diabetes: a consensus approach-National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis. 2000;36:646-661.